$562 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 59 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 101.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMMU | Sell | IMMUNOMEDICS INC | $112,433,000 | +31.5% | 4,750,000 | -18.8% | 20.02% | +43.4% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $51,520,000 | -28.4% | 4,025,000 | -5.5% | 9.17% | -22.0% |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $45,562,000 | -16.8% | 1,162,000 | +4.2% | 8.11% | -9.4% |
| ARGX | Buy | ARGENX SEsponsored adr | $37,555,000 | +15.6% | 453,233 | +12.2% | 6.68% | +26.0% |
| KDMN | Buy | KADMON HLDGS INC | $36,149,000 | +42.9% | 9,060,014 | +52.3% | 6.44% | +55.8% |
| VCYT | Sell | VERACYTE INC | $24,846,000 | +34.7% | 2,660,210 | -19.8% | 4.42% | +46.8% |
| CEMI | Buy | CHEMBIO DIAGNOSTICS INC | $22,539,000 | +40.4% | 2,030,533 | +1.2% | 4.01% | +53.0% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $20,695,000 | -41.8% | 311,111 | -42.8% | 3.68% | -36.6% |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS IN | $14,012,000 | +10.3% | 1,030,330 | -41.5% | 2.49% | +20.2% |
| IRIX | IRIDEX CORP | $13,920,000 | +21.7% | 2,000,000 | 0.0% | 2.48% | +32.7% | |
| Buy | INTEC PHARMA LTD JERUSALEM | $13,035,000 | -24.4% | 2,962,568 | +8.7% | 2.32% | -17.6% | |
| VRAY | Sell | VIEWRAY INC | $10,345,000 | -13.2% | 1,495,000 | -19.3% | 1.84% | -5.3% |
| CASM | Buy | CAS MED SYS INC | $10,264,000 | +56.2% | 5,263,508 | +0.9% | 1.83% | +70.1% |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $9,734,000 | – | 34,803 | +100.0% | 1.73% | – |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $9,686,000 | -67.5% | 830,000 | -28.1% | 1.72% | -64.6% |
| XBI | Sell | SPDR SERIES TRUSTput | $9,519,000 | -78.3% | 100,000 | -80.0% | 1.70% | -76.3% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $7,931,000 | – | 60,000 | +100.0% | 1.41% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $7,118,000 | – | 750,000 | +100.0% | 1.27% | – |
| REGN | New | REGENERON PHARMACEUTICALSput | $6,900,000 | – | 20,000 | +100.0% | 1.23% | – |
| EEM | Buy | ISHARES TRput | $6,500,000 | +34.6% | 150,000 | +50.0% | 1.16% | +46.6% |
| OBSV | New | OBSEVA SA | $6,424,000 | – | 424,300 | +100.0% | 1.14% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $6,323,000 | – | 160,000 | +100.0% | 1.13% | – |
| ASMB | Sell | ASSEMBLY BIOSCIENCES INCcall | $5,783,000 | -24.1% | 147,500 | -4.8% | 1.03% | -17.3% |
| ZGNX | New | ZOGENIX INC | $4,884,000 | – | 110,500 | +100.0% | 0.87% | – |
| CHRS | New | COHERUS BIOSCIENCES INC | $4,830,000 | – | 345,000 | +100.0% | 0.86% | – |
| CUTR | Buy | CUTERA INC | $4,232,000 | +20.3% | 105,000 | +50.0% | 0.75% | +31.0% |
| XENE | New | XENON PHARMACEUTICALS INC | $4,140,000 | – | 450,000 | +100.0% | 0.74% | – |
| AERI | Buy | AERIE PHARMACEUTICALS INCput | $4,122,000 | +659.1% | 61,000 | +510.0% | 0.73% | +724.7% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $3,696,000 | – | 168,000 | +100.0% | 0.66% | – |
| ZGNX | New | ZOGENIX INCcall | $3,647,000 | – | 82,500 | +100.0% | 0.65% | – |
| MEIP | New | MEI PHARMA INC | $3,468,000 | – | 880,087 | +100.0% | 0.62% | – |
| New | INOTEK PHARMACEUTICALS CORPnote 5.750% 8/0 | $3,022,000 | – | 3,000,000 | +100.0% | 0.54% | – | |
| ARWR | New | ARROWHEAD PHARMACEUTICALS INcall | $2,720,000 | – | 200,000 | +100.0% | 0.48% | – |
| FENC | FENNEC PHARMACEUTICALS INC | $2,610,000 | -13.7% | 250,000 | 0.0% | 0.46% | -5.9% | |
| ZFGN | New | ZAFGEN INC | $2,558,000 | – | 250,000 | +100.0% | 0.46% | – |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INCcall | $2,432,000 | -29.2% | 190,000 | -6.5% | 0.43% | -22.8% |
| ACER | New | ACER THERAPEUTICS INC | $2,360,000 | – | 109,270 | +100.0% | 0.42% | – |
| MGTA | New | MAGENTA THERAPEUTICS INC | $2,295,000 | – | 170,000 | +100.0% | 0.41% | – |
| TSRO | New | TESARO INC | $2,224,000 | – | 50,000 | +100.0% | 0.40% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lcall | $2,126,000 | – | 53,800 | +100.0% | 0.38% | – |
| ZGNX | New | ZOGENIX INCput | $1,989,000 | – | 45,000 | +100.0% | 0.35% | – |
| VCEL | New | VERICEL CORP | $1,844,000 | – | 190,055 | +100.0% | 0.33% | – |
| EDIT | New | EDITAS MEDICINE INCcall | $1,792,000 | – | 50,000 | +100.0% | 0.32% | – |
| KZR | New | KEZAR LIFE SCIENCES INC | $1,730,000 | – | 100,000 | +100.0% | 0.31% | – |
| DB | New | DEUTSCHE BANK AGput | $1,593,000 | – | 150,000 | +100.0% | 0.28% | – |
| FTSV | New | FORTY SEVEN INC | $1,168,000 | – | 73,000 | +100.0% | 0.21% | – |
| AMAG | AMAG PHARMACEUTICALS INCput | $975,000 | -3.3% | 50,000 | 0.0% | 0.17% | +5.5% | |
| ESPR | New | ESPERION THERAPEUTICS INC NEput | $980,000 | – | 25,000 | +100.0% | 0.17% | – |
| ALIM | ALIMERA SCIENCES INC | $953,000 | -5.1% | 974,318 | 0.0% | 0.17% | +3.7% | |
| OSUR | ORASURE TECHNOLOGIES INCput | $824,000 | -2.5% | 50,000 | 0.0% | 0.15% | +6.5% | |
| STAA | New | STAAR SURGICAL COput | $775,000 | – | 25,000 | +100.0% | 0.14% | – |
| VIVE | Sell | VIVEVE MED INC | $728,000 | -71.0% | 267,500 | -61.0% | 0.13% | -68.3% |
| CHRS | New | COHERUS BIOSCIENCES INCcall | $700,000 | – | 50,000 | +100.0% | 0.12% | – |
| PTE | New | POLARITYTE INCput | $589,000 | – | 25,000 | +100.0% | 0.10% | – |
| ZYNE | New | ZYNERBA PHARMACEUTICALS INCput | $487,000 | – | 50,000 | +100.0% | 0.09% | – |
| MNKD | Sell | MANNKIND CORPput | $204,000 | -32.5% | 107,500 | -18.9% | 0.04% | -26.5% |
| RMTI | Sell | ROCKWELL MED INCput | $123,000 | -92.3% | 25,000 | -91.8% | 0.02% | -91.5% |
| TRXC | Sell | TRANSENTERIX INCput | $109,000 | -64.5% | 25,000 | -86.1% | 0.02% | -62.0% |
| ONS | ONCOBIOLOGICS INC | $25,000 | -3.8% | 29,082 | 0.0% | 0.00% | 0.0% | |
| ENDP | Exit | ENDO INTL PLCput | $0 | – | -60,000 | -100.0% | -0.06% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDput | $0 | – | -25,000 | -100.0% | -0.07% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGput | $0 | – | -10,000 | -100.0% | -0.08% | – |
| GKOS | Exit | GLAUKOS CORPput | $0 | – | -20,000 | -100.0% | -0.10% | – |
| TWTR | Exit | TWITTER INCput | $0 | – | -25,000 | -100.0% | -0.12% | – |
| ANIP | Exit | ANI PHARMACEUTICALS INCput | $0 | – | -14,300 | -100.0% | -0.14% | – |
| NVTRQ | Exit | NUVECTRA CORP | $0 | – | -66,724 | -100.0% | -0.14% | – |
| SGMO | Exit | SANGAMO THERAPEUTICS INCput | $0 | – | -50,000 | -100.0% | -0.16% | – |
| AMPE | Exit | AMPIO PHARMACEUTICALS INCput | $0 | – | -325,000 | -100.0% | -0.18% | – |
| AXDX | Exit | ACCELERATE DIAGNOSTICS INCcall | $0 | – | -50,000 | -100.0% | -0.19% | – |
| BEAT | Exit | BIOTELEMETRY INC | $0 | – | -40,000 | -100.0% | -0.20% | – |
| TSRO | Exit | TESARO INCcall | $0 | – | -25,000 | -100.0% | -0.23% | – |
| RARX | Exit | RA PHARMACEUTICALS INC | $0 | – | -270,000 | -100.0% | -0.23% | – |
| TWTR | Exit | TWITTER INCcall | $0 | – | -50,000 | -100.0% | -0.24% | – |
| FIXX | Exit | HOMOLOGY MEDICINES INC | $0 | – | -79,000 | -100.0% | -0.24% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INCput | $0 | – | -75,000 | -100.0% | -0.26% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INCcall | $0 | – | -30,000 | -100.0% | -0.27% | – |
| EDIT | Exit | EDITAS MEDICINE INCput | $0 | – | -55,000 | -100.0% | -0.30% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DELput | $0 | – | -25,000 | -100.0% | -0.46% | – |
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -559,739 | -100.0% | -0.46% | – | |
| Exit | INOTEK PHARMACEUTICALS CORPnote 5.750% 8/0 | $0 | – | -3,000,000 | -100.0% | -0.47% | – | |
| ARMO | Exit | ARMO BIOSCIENCES INC | $0 | – | -80,000 | -100.0% | -0.49% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.50% | – |
| FXI | Exit | ISHARES TRput | $0 | – | -75,000 | -100.0% | -0.58% | – |
| LLY | Exit | LILLY ELI & COput | $0 | – | -75,000 | -100.0% | -0.95% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -350,000 | -100.0% | -1.07% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -1,346,360 | -100.0% | -1.09% | – |
| AVXS | Exit | AVEXIS INC | $0 | – | -60,000 | -100.0% | -1.21% | – |
| QQQ | Exit | POWERSHARES QQQ TRUSTput | $0 | – | -85,000 | -100.0% | -2.22% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -200,000 | -100.0% | -4.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
| IRIDEX CORP | 20 | Q3 2019 | 8.1% |
| ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
| IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
| VERACYTE INC | 19 | Q3 2019 | 10.1% |
| ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
| XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
| CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
| APELLIS PHARMACEUTICALS INC | 17 | Q3 2023 | 18.4% |
| KURA ONCOLOGY INC. COMMON STOCK | 17 | Q3 2023 | 8.1% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
| Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
| IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
| CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.